It has been demonstrated that overexpression of USP2 inhibited TLR/IL-1β-induced NF-κB activation through deubiquitination of tumor necrosis factor receptor-associated factor 6 (TRAF6) in human colon cancer cells [22]. Here, USP2 is linked to colonic neoplasm.